Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00274456
Status:
COMPLETED
Last Update Posted:
2019-11-21
First Post:
2006-01-10
Brief Title:
Phase II Trial Comparing ABI-007 Abraxane Nab-Paclitaxel to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer
Sponsor:
Celgene
Organization:
Celgene
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Metastatic breast cancer nab paclitaxel docetaxel | View |